Chinese Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows

Hunan Jiudian Pharmaceutical

Market Cap: CN¥8.5b

Researches, develops, produces, and sells pharmaceutical products in China and internationally.

Xiamen Amoytop Biotech

Market Cap: CN¥31.7b

Engages in research, development, production, and sale of recombinant protein drugs in China.

Zhejiang Wolwo Bio-Pharmaceutical

Market Cap: CN¥10.7b

A biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally.

Zhejiang Tianyu Pharmaceutical

Market Cap: CN¥6.3b

Engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally.

Betta Pharmaceuticals

Market Cap: CN¥22.4b

Researches and develops, manufactures, and markets medicines for the treatment of cancer in China.

Suzhou Zelgen BiopharmaceuticalsLtd

Market Cap: CN¥26.5b

Suzhou Zelgen Biopharmaceuticals Co.,Ltd.

Walvax Biotechnology

Market Cap: CN¥17.3b

Researches, develops, produces, and markets vaccines in China.

CSPC Innovation Pharmaceutical

Market Cap: CN¥58.6b

Engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally.

GemPharmatech

Market Cap: CN¥4.7b

A contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide.

Zhejiang Garden BiopharmaceuticalLtd

Market Cap: CN¥7.4b

Zhejiang Garden Biopharmaceutical Co.,Ltd.